Navigation Links
Nasal Anthrax Vaccine Proves Effective in Animal Study
Date:8/31/2007

Though not ready for humans, it offered immunity for at least 6 months

FRIDAY, Aug. 31 (HealthDay News) -- An experimental nasal anthrax vaccine proved highly effective in tests in mice and guinea pigs, a University of Michigan Medical School study shows.

After it was placed inside the animals' noses, the vaccine triggered a strong immune response. All immunized guinea pigs survived after they received injections of 1,000 times the lethal dose of anthrax spores. All unprotected guinea pigs died.

From 40 percent to 70 percent of immunized animals survived after large doses of anthrax spores were placed directly in their nasal tissue.

In these animal experiments, there have been no significant side effects, and the vaccine has produced effective immunity for at least six months, the study said.

The nasal vaccine features tiny soybean oil droplets that are small enough to carry an anthrax protein inside the nasal membrane. Immune system cells then react to the anthrax protein and prime the entire immune system to attack anthrax.

This nasal vaccine is easier and more effective than the current injectable vaccine, according to the researchers. The nasal vaccine is also easier to store and use in locations where there is no available refrigeration.

The next step is to test whether the vaccine produces immunity in primates. The researchers are also preparing plans for safety studies in humans.

The study was published in the August issue of Infection and Immunity.

More information

The U.S. Centers for Disease Control and Prevention has more about anthrax.



-- Robert Preidt



SOURCE: University of Michigan Health System, news release, August 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Nasal Spray Could Take Drugs Direct to Brain.
2. Nasal Spray Could Take Drugs Directly to Brain
3. Nasal Spray Beats Antihistamine
4. Nasal sprays used for other ailments!
5. Chronic Sinusitis May Be Related To Nasal Mucus
6. Stress – Buster : Hormonal Nasal Spra
7. CDC To Conduct Pre-clinical Trails Of BioDiems Intranasal Bird Flu Vaccine
8. Cluster Headaches Can Be Treated By Nasal Spray
9. Nasal Plastic Surgery Improves Airway Function
10. Compellis Pharmaceuticals Gets Patent for Obesity-Fighting Nasal Spray CP404
11. Patients Dissatisfied Following Closed Reduction Of Nasal Fractures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... New Jersey (PRWEB) , ... February 27, 2017 , ... ... highest cancer rates, among all types and genders. And the need for advanced services ... by RWJ and its top-rated cancer care program, in collaboration with their non-profit partners ...
(Date:2/26/2017)... ... February 26, 2017 , ... Today, A' Design Awards ... of International Social Design Awards. , The 7th A' Social Design Award ... and Institutions worldwide with realized projects and conceptual works. , The first phase ...
(Date:2/26/2017)... , ... February 26, 2017 , ... NuevaCare, a leading ... diverse as Millbrae, Belmont, and Palo Alto, is proud to announce an important upgrade ... Area consumers look for home care close to home, and by having city-specific pages, ...
(Date:2/26/2017)... ... ... IndustryArchive.Org . is announcing a new way for B2B Sellers to ... pay for B.A.N.T. quality sales leads based on the Sellers decision to purchase a ... that B2B buyers are controlling the sales process via the Internet and that ad ...
(Date:2/26/2017)... ... February 26, 2017 , ... ODH, Inc.™ announced today it will exhibit ... Sheraton Pentagon City Hotel in Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, ... to improve Medicaid population health management. , ODH will also have an exhibit booth ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... , Feb. 27, 2017  International Biophysics Corporation, a ... , today announced a 34% revenue growth in 2016 ... increase in unit sales.  This growth was fueled by its ... in addition to the expansion of its global sales of ... International Biophysics, CEO, "As we enter our 25 th ...
(Date:2/27/2017)... ROCKVILLE, Md. , Feb. 27, 2017 /PRNewswire/ ... "RegeneRx"), a clinical-stage drug development company focused on ... its licensee for RGN-137, GtreeBNT Co., Ltd., received ... its Phase 3 clinical trial design for RGN-137 ... dermal wound healing gel that incorporates Thymosin beta ...
(Date:2/27/2017)... 27, 2017 Leading Countries, Technologies and Companies ... expected to grow at a CAGR of 8.9% from 2016-2021 and ... at a CAGR of 9.1% from 2016 to 2027. The market ... ... benefit you Read on to discover how you can exploit ...
Breaking Medicine Technology: